Furthermore, its soluble domain of the receptor expressed on myeloid cells 2 is closely associated with tau-related neurodegeneration, and it is suggested to be non-specific for AD, but useful for detecting a microglia response induced by any neuronal damage. The gene discussed is MAPT; the disease is Alzheimer disease.